News

Information Jul 28, 2025
Our Operating Officer & CSO, Tasuku Ishida, to Deliver an Invited Lecture at 3rd Targeted Protein Degradation Conference in Japan
Information Jul 23, 2025
Article on the Provision of Elix Discovery™ to Eisai Featured in FirstWord Pharma and AI BRIEF
Information Jul 19, 2025
Article on the Commercialization of a Federated Learning-Based AI Drug Discovery Platform Featured in BioPharmaTrend, AI BRIEF, and eCommerceNews
Information Jul 18, 2025
Article on the Commercialization of a Federated Learning-Based AI Drug Discovery Platform Featured in The Nikkei Biotech ONLINE, Nikkan Kogyo Shimbun Digital Edition, Biz/Zine, and AnswersNews
News Release Jul 17, 2025
Elix Provides AI Drug Discovery Platform “Elix Discovery™” to Eisai
News Release Jul 15, 2025
Elix and LINC Become the First in the World to Commercialize an AI Drug Discovery Platform Incorporating Federated Learning-Based AI Models Trained on Data from 16 Pharmaceutical Companies
Information May 15, 2025
Our Application Scientist, Takahiro Inoue, to Participate as a Speaker in the 29th Tutorial Hosted by the Conference on Biomolecular Screenology (Online)
Information May 14, 2025
Our CEO, Shinya Yuki, to Deliver a Presentation at FJS 2025
Information Apr 17, 2025
Article on Partnership with PRISM BioLab Featured in Nikkei Biotech ONLINE
Information Apr 16, 2025
Article on Partnership with PRISM BioLab Featured in Nikkei

Contact Us

Thank you for your interest in Elix. If you have any inquiries about our AI drug discovery platform or conducting joint research, or if you would like to conduct an interview with us, please click the Contact button on the right to get in touch with us.
We will respond as soon as possible.